2022-2024年湖南省某医院儿童感染沙门菌血清型及耐药性

Serotypes and antimicrobial resistance of Salmonella infections in children at a hospital in Hunan Province from 2022 to 2024

  • 摘要: 目的 探究湖南省儿童医院儿童粪便标本中沙门菌的检出情况及其血清型、耐药性的变迁,为沙门菌感染的诊断、治疗提供参考依据。方法 回顾性分析2022-2024年儿童粪便标本中沙门菌检出情况、血清型以及对抗菌药物耐药性的变化,并用卡方检验对相关数据进行分析与比较。结果 2022-2024年沙门菌检出株数分别为121、139、123株。其中鼠伤寒沙门菌检出率最高,占67.62%(259/383)。5-10月份沙门菌检出率最高,占78.85%(302/383)。男女检出占比为1.62∶1(237/146),不同年龄段儿童沙门菌检出率也有区别,其中28 d~1岁儿童检出率最高,占61.62%(236/383)。383株沙门菌对抗菌药物的耐药性三年间无明显差异,其中对磺胺甲噁唑/甲氧苄啶耐药率为42.04%,对头孢曲松耐药率为40.37%。结论 该地区夏秋季1岁以下男童易感染沙门菌,其中鼠伤寒沙门菌为主要血清型。从2023年开始出现对碳青霉烯抗菌药物耐药的菌株,根据药敏结果,治疗可优先选择三代以上头孢菌素类抗菌药物,临床应重视本地区沙门菌感染的特征及耐药性变化,尽早诊断及合理使用抗菌药物。

     

    Abstract: OBJECTIVE To investigate the detection rate, serotype distribution and antimicrobial resistance trends of Salmonella in fecal specimens from children at Hunan Children's Hospital, and to provide reference for the diagnosis and treatment of Salmonella infections. METHODS A retrospective analysis was conducted on the detection rate, serotype distribution and antimicrobial resistance trends of Salmonella in children's fecal specimens from 2022 to 2024. Chi-square tests were employed for data analysis and comparison. RESULTS The number of Salmonella isolates from 2022-2024 was 121, 139 and 123, respectively. Salmonella typhimurium had the highest detection rate at 67.62% (259/383). The detection rate of Salmonella peaked from May to Oct., accounting for 78.85% (302/383). The male-to-female detection ratio was 1.62∶1 (237/146). The detection rates varied across age groups, with the highest rate (61.62%, 236/383) observed in children aged 28 days to 1 year. Over the three years, antimicrobial resistance among the 383 Salmonella isolates showed no significant changes, with resistance rates of 42.04% to sulfamethoxazole/trimethoprim and 40.37% to ceftriaxone. CONCLUSIONS In this region, male children under 1 year old are more susceptible to Salmonella infections during summer and autumn, with S. typhimurium being the predominant serotype. Carbapenem-resistant strains first emerged in 2023. Based on antimicrobial susceptibility testing, third-generation cephalosporins may be prioritized for treatment. Clinicians should monitor local Salmonella infection characteristics and resistance trends to ensure early diagnosis and rational antimicrobial use.

     

/

返回文章
返回